- Home
- FRHC vs APLS Comparison
FRHC vs APLS Comparison
Compare FRHC & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRHC
- APLS
- Stock Information
- Founded
- FRHC 1981
- APLS 2009
- Country
- FRHC Kazakhstan
- APLS United States
- Employees
- FRHC N/A
- APLS N/A
- Industry
- FRHC Investment Bankers/Brokers/Service
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- FRHC Finance
- APLS Health Care
- Exchange
- FRHC Nasdaq
- APLS Nasdaq
- Market Cap
- FRHC 6.1B
- APLS 4.4B
- IPO Year
- FRHC N/A
- APLS 2017
- Fundamental
- Price
- FRHC $105.37
- APLS $27.92
- Analyst Decision
- FRHC
- APLS Buy
- Analyst Count
- FRHC 0
- APLS 17
- Target Price
- FRHC N/A
- APLS $68.00
- AVG Volume (30 Days)
- FRHC 66.1K
- APLS 3.2M
- Earning Date
- FRHC 11-08-2024
- APLS 10-30-2024
- Dividend Yield
- FRHC N/A
- APLS N/A
- EPS Growth
- FRHC 60.79
- APLS N/A
- EPS
- FRHC 5.74
- APLS N/A
- Revenue
- FRHC $1,156,769,000.00
- APLS $628,786,000.00
- Revenue This Year
- FRHC N/A
- APLS $102.59
- Revenue Next Year
- FRHC N/A
- APLS $31.18
- P/E Ratio
- FRHC $17.53
- APLS N/A
- Revenue Growth
- FRHC 90.07
- APLS 240.74
- 52 Week Low
- FRHC $64.00
- APLS $26.28
- 52 Week High
- FRHC $105.42
- APLS $73.80
- Technical
- Relative Strength Index (RSI)
- FRHC 73.07
- APLS 33.88
- Support Level
- FRHC $96.00
- APLS $26.28
- Resistance Level
- FRHC $101.01
- APLS $28.62
- Average True Range (ATR)
- FRHC 2.33
- APLS 1.16
- MACD
- FRHC 0.37
- APLS 0.29
- Stochastic Oscillator
- FRHC 99.60
- APLS 50.93
About FRHC Freedom Holding Corp.
Freedom Holding Corp is a holding company with its subsidiary it is engaged in securities brokerage, securities dealing for customers and account, market-making activities, investment research, investment counseling, investment banking services, retail and commercial banking, insurance products, payment services, and information processing services. It acts as a professional participant through its subsidiaries on the Kazakhstan Stock Exchange (KASE), Moscow Exchange (MOEX), Saint-Petersburg Exchange (SPB), the Ukrainian Exchange, the Uzbek Republican Currency Exchange (UZCE), and the Republican Stock Exchange of Tashkent (UZSE). Its segments are Brokerage, Banking, Insurance, and Others.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.